We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Stockal+Disclaimer.pdf
13 own
15 watching
Current Price
$7.98
$-0.25
(-3.04%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
532.58M
52-Week High
12.93000
52-Week Low
4.80000
Average Volume
0.52M
Dividend Yield
--
P/E Ratio
--
Market Capitalization532.58M52-Week High12.9300052-Week Low4.80000Average Volume0.52MDividend Yield--P/E Ratio--What does the Stockal+Disclaimer.pdf do?
CareDx, Inc., a molecular diagnostics company, focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in the United States and internationally. The company's commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection. It is also developing AlloSure, a next-generation sequencing-based test to detect donor-derived cell-free DNA after transplantation. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Stock Options Channel
10 months ago
Investors eyeing a purchase of CareDx Inc (CDNA) shares, but cautious about paying the going market price of 8.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2024 put at the &#...
Globe Newswire
1 year ago
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of LifeStance Health Group, Inc., Berry Corporation, CareDx, Inc., and Opendoor Technologies Inc. If you are a current owner of shares of any of these ...
Ticker Report
1 year ago
CareDx, Inc (NASDAQ:CDNA Get Rating) insider Reginald Seeto sold 2,818 shares of the stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $8.95, for a total transaction of $25,221.10. Following the transaction, the insider now owns 537,815 ...
Business Wire
1 year ago
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF continues its investigation into CareDx, Inc. (NasdaqGM: CDNA). In October 2021, the Company disclosed that it received a civil investigative...
Business Wire
1 year ago
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today commented on the release of a Billing Article related to MolDX Molecular Testing...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
Can Indians buy Stockal+Disclaimer.pdf shares?
How can I buy Stockal+Disclaimer.pdf shares from India?
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
What is today’s traded volume of Stockal+Disclaimer.pdf?
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
Current Price
$7.98
$-0.25
(-3.04%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.